TaiMed Biologics Inc
TPEX:4147
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TaiMed Biologics Inc
TPEX:4147
|
TW |
|
N
|
Nusa Konstruksi Enjiniring Tbk PT
IDX:DGIK
|
ID |
|
Bavarian Nordic A/S
F:BV3A
|
DK |
|
C
|
Caprock Mining Corp
CNSX:CAPR
|
CA |
|
Adlai Nortye Ltd
F:N2U0
|
KY |
|
W
|
Wonbiogen Co Ltd
KOSDAQ:307280
|
KR |
|
N
|
Next Capital PCL
SET:NCAP
|
TH |
|
Ushio Inc
TSE:6925
|
JP |
|
Black Diamond Group Ltd
F:8B8
|
CA |
|
Stelco Holdings Inc
TSX:STLC
|
CA |
|
Mobimo Holding AG
F:M1H
|
CH |
|
Amaero Ltd
ASX:3DA
|
AU |
|
N
|
Neogen Corp
F:NG2
|
US |
|
A
|
Avax SA
ATHEX:AVAX
|
GR |
Bankruptcy Probability
TaiMed Biologics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
TaiMed Biologics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TW |
T
|
TaiMed Biologics Inc
TPEX:4147
|
16.1B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
497.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
230.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
190.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
126.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
90.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
TaiMed Biologics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, TaiMed Biologics Inc has total debt of 447.7m TWD. This includes both short-term (0 TWD) and long-term (447.7m TWD) debt.
You can find a full breakdown on its Balance Sheet.